U.S. Markets close in 55 mins

GlaxoSmithKline plc -- Moody's: M&A greatest downside risk to European pharma companies' credit quality in 2018

M&A poses downside risks to the credit quality of Europe's six largest pharmaceutical companies in 2018 and will likely dampen any benefits from expected improvements in operating performance in the coming ...